Literature DB >> 2684631

Membrane interactions of diphtheria toxin analyzed using in vitro synthesized mutants.

S McGill1, H Stenmark, K Sandvig, S Olsnes.   

Abstract

We have developed a system to study the interactions of diphtheria toxin with the cell surface using non-toxic mutant proteins synthesized in vitro. Proteins obtained by N-terminal deletions containing the whole B fragment bound strongly to cells. Deletions extending into the B fragment did not yield an autonomous binding domain. Loss of only the N-terminal 3 kd of the B fragment significantly impaired the ability to recognize the receptor. This, together with previous reports that the C-terminal end of the B fragment is required for binding, suggests that both ends of the B fragment are necessary for receptor recognition. Receptor bound diphtheria toxin undergoes a conformational change at pH less than 5.3 that results in translocation of the A fragment to the cytosol and the appearance of a B fragment-derived 25 kd polypeptide (P25) resistant to externally applied protease. Only the B fragment was required for generation of P25. N-terminal deletions of 130 amino acids or more resulted in proteins that gave rise to P25 at higher pH than full length toxin. Furthermore, a second protease-inaccessible polypeptide of 18 kd (P18) was observed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684631      PMCID: PMC401336          DOI: 10.1002/j.1460-2075.1989.tb08431.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  31 in total

Review 1.  Diphtheria toxin.

Authors:  A M Pappenheimer
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  An efficient mRNA-dependent translation system from reticulocyte lysates.

Authors:  H R Pelham; R J Jackson
Journal:  Eur J Biochem       Date:  1976-08-01

4.  Association of diphtheria toxin with Vero cells. Demonstration of a receptor.

Authors:  J L Middlebrook; R B Dorland; S H Leppla
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

5.  Rapid entry of nicked diphtheria toxin into cells at low pH. Characterization of the entry process and effects of low pH on the toxin molecule.

Authors:  K Sandvig; S Olsnes
Journal:  J Biol Chem       Date:  1981-09-10       Impact factor: 5.157

6.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

7.  Permeabilization of the plasma membrane by deletion mutants of diphtheria toxin.

Authors:  H Stenmark; S McGill; S Olsnes; K Sandvig
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

8.  Primary structure of diphtheria toxin fragment B: structural similarities with lipid-binding domains.

Authors:  P Lambotte; P Falmagne; C Capiau; J Zanen; J M Ruysschaert; J Dirkx
Journal:  J Cell Biol       Date:  1980-12       Impact factor: 10.539

9.  The entry of diphtheria toxin into the mammalian cell cytoplasm: evidence for lysosomal involvement.

Authors:  R K Draper; M I Simon
Journal:  J Cell Biol       Date:  1980-12       Impact factor: 10.539

10.  Diphtheria toxin entry into cells is facilitated by low pH.

Authors:  K Sandvig; S Olsnes
Journal:  J Cell Biol       Date:  1980-12       Impact factor: 10.539

View more
  12 in total

1.  Association between diphtheria toxin A- and B-fragment and their fusion proteins.

Authors:  H Stenmark; B N Afanasiev; S Ariansen; S Olsnes
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

2.  Membrane translocation of diphtheria toxin carrying passenger protein domains.

Authors:  I H Madshus; S Olsnes; H Stenmark
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

3.  Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor requires both activation of receptor tyrosine kinase and growth factor internalization.

Authors:  A Wiedłocha; P O Falnes; A Rapak; R Muñoz; O Klingenberg; S Olsnes
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

4.  Subcloning and characterization of the binding domain of fragment B of diphtheria toxin.

Authors:  Q Y Esbensen; P O Falnes; S Olsnes; I H Madshus
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

5.  Modulation of the intracellular stability and toxicity of diphtheria toxin through degradation by the N-end rule pathway.

Authors:  P O Falnes; S Olsnes
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

6.  Phosphorylation-regulated nucleocytoplasmic trafficking of internalized fibroblast growth factor-1.

Authors:  Antoni Wiedłocha; Trine Nilsen; Jørgen Wesche; Vigdis Sørensen; Jedrzej Małecki; Ewa Marcinkowska; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

7.  Cloning of an intracellular protein that binds selectively to mitogenic acidic fibroblast growth factor.

Authors:  E Kolpakova; A Wiedłocha; H Stenmark; O Klingenberg; P O Falnes; S Olsnes
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

8.  Ability of methotrexate to inhibit translocation to the cytosol of dihydrofolate reductase fused to diphtheria toxin.

Authors:  O Klingenberg; S Olsnes
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

9.  GPI-anchored diphtheria toxin receptor allows membrane translocation of the toxin without detectable ion channel activity.

Authors:  M Lanzrein; O Sand; S Olsnes
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

10.  Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector.

Authors:  A Wiedlocha; I H Madshus; H Mach; C R Middaugh; S Olsnes
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.